Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02127164 · ClinicalTrials.gov registry record · NA

Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

A NA study of Gastrointestinal Injury and Complicated Diverticulitis, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT02127164 is a NA study of Gastrointestinal Injury and Complicated Diverticulitis that has completed, run by University of Arizona. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02127164, a NA study of Gastrointestinal Injury and Complicated Diverticulitis, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose using the vacuum assisted device with Dakin's solution on patients undergoing emergency surgery for hollow viscus perforation installed immediately at the end of operation and remained there for the first 3 postoperative days, followed by delayed primary closure on postoperative day 4. The investigators believe this technique can achieve earlier wound closure, decrease patient discomfort, improve cost savings, and potentially standardize and revolutionize the investigators management of heavily contaminated wounds.

Interventions

  • DEVICE "Veraflo" device, Dakin's solution

Study Locations (1)

Arizona

  • University of Arizona Medical Center - Tucson

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-05
Est. Completion 2017-06
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT02127164

The ClinicalTrials.gov registry entry for NCT02127164 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastrointestinal Injury appearing as the primary indexed condition, and to 1 intervention - of which "Veraflo" device, Dakin's solution is the first listed.

NCT02127164 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT02127164 about?

NCT02127164 is a clinical study titled "Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries". Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose ...

What is the current status of trial NCT02127164?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-05. Estimated completion is 2017-06.

What conditions does trial NCT02127164 study?

This clinical trial studies the following conditions: Gastrointestinal Injury, Complicated Diverticulitis.

What interventions are being tested in trial NCT02127164?

The interventions under investigation include: "Veraflo" device, Dakin's solution (DEVICE).

Who is sponsoring clinical trial NCT02127164?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02127164 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.